$SANION #Saniona AB Saniona - Competitor Soleno fails Phase 3 in PWS: Soleno’s diazoxide choline latest project to fail in PWS Strong placebo effect in the primary endpoint HQ-CT Why we believe Saniona has a better chance in PWS https://t.co/NUYLu3hnjv #equity #stocks https://t.co/DadLdECAyA